Clinical and Translational Science
Clinical and Translational Science is a journal indexed in SJR in Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous) with an H index of 65. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on translational medicine, precision medicine, translational studies, quantitative pharmacology. It has an SJR impact factor of 1,219 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,219.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,219
H-index
65
Docs (year)
324
Docs 3y
768
Total refs
11208
Cites 3y
2984
Citable 3y
742
Cites/Doc 2y
3.06
Ref/Doc
34.59
Immediate OA
2700 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Building Capacity Across the Spectrum of Research Translation: Centers of Excellence within the Rochester Clinical and Translational Science Institute
View moreVision and Status of the Critical Path Initiative
View moreEndoluminal Vacuum Therapy for Ivor Lewis Anastomotic Leaks: A Pilot Study in a Swine Model
View moreEffectiveness and Cost of Recruiting Participants to a Research Registry Using an Emergency Department Research Associate Program
View moreEffect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure
View moreCYP2C9
View moreCTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes
View moreComprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development
View moreComparing Model Performance in Characterizing the PK/PD of the Anti-Myostatin Antibody Domagrozumab
View moreClinicalTrials.gov Reporting: Strategies for Success at an Academic Health Center
View moreClinical Data: Sources and Types, Regulatory Constraints, Applications
View moreClinical and Translational Science: From Bench-Bedside to Global Village
View moreClinical and Translational Research and Community Engagement: Implications for Researcher Capacity Building
View moreA Comparative Study of Patients' Attitudes Toward Clinical Research in the United States and Urban and Rural China
View moreBitransgenesis with beta2-Adrenergic Receptors or Adenylyl Cyclase Fails to Improve beta1-Adrenergic Receptor Cardiomyopathy
View moreBeyond Translational Research from T1 to T4: Beyond "Separate but Equal" to Integration (Ti)
View moreAssessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal
View moreAre Th17 Cells an Appropriate New Target in the Treatment of Rheumatoid Arthritis?
View moreAchievements in Health Equity: Nesting an NIMHD Center of Excellence within a CTSA
View moreAccess to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
View moreA Study of The Relationship between The Interleukin-6 Gene and Obstructive Sleep Apnea
View moreA QUICK ROUND UP OF NEWS AND INFORMATION FROM OUR COMMUNITY
View moreA Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability
View moreA New Class of Human Mast Cell and Peripheral Blood Basophil Stabilizers that Differentially Control Allergic Mediator Release
View more